Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:31 PM
Ignite Modification Date:
2025-12-24 @ 5:31 PM
NCT ID:
NCT07073768
Eligibility Criteria:
Inclusion Criteria:
* • Type 2 Diabetic patients visiting Medical OPD
* Patients already maintaining lifestyle modifications and on metformin monotherapy, but not achieving target HbA1c levels.
* Patients who require treatment with a DPP-4 inhibitors
* Patients with baseline HbA1c \> 6.5% and \< 10%
* Patients willing to provide written informed consent prior to recruitment
Exclusion Criteria:
* • Type 1 Diabetic Patients
* Patients already using Trelagliptin for type 2 diabetes
* Patients with severe renal impairment (eGFR \< 30ml/min/1.73m2 or on dialysis)
* Patients with Serious Heart disease or Cerebrovascular disease
* Patients with Serious Pancreatic or blood disease
* Patients with malignancy
* Patients with history of hypersensitivity to DPP-4 inhibitors
* Patients with history of gastrointestinal resection
* Pregnant, Breast feeding or planning to be pregnant patients
* Patients participating in other clinical studies
* Patients assessed as ineligible by researchers due to any other reason
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT07073768
Study Brief:
Protocol Section:
NCT07073768